Aliment Pharmacol Ther 2010; 32: 1297–1306 Summary Background Patients with
ulcerative colitis (UC) that is chronically active despite 5‐aminosalicylates or …

Abstract Background and Aims: Adsorptive granulocyte/monocyte apheresis (GMA) has
shown promising efficacy in the treatment of patients with ulcerative colitis (UC). But a sham …

Methods This was a multicenter study in China involving four institutions and 34 patients
with active UC. Baseline conventional medications were continued without changing the …

Active ulcerative colitis (UC) is frequently associated with infiltration of a large number of
leukocytes into the bowel mucosa. Therefore, removal of activated circulating leukocytes by …

OBJECTIVES: Granulocyte and monocyte adsorptive apheresis (GMA) has shown efficacy in
patients with active ulcerative colitis (UC). However, with routine weekly treatment, it may …

Background This prospective study was to assess the safety and feasibility of daily
granulocyte and monocyte adsorptive apheresis (GMA) therapy in patients with active …

The purpose of this meta-analysis was to determine whether selective adsorptive
granulocyte and monocyte apheresis (GMA apheresis) using the Adacolumn® device can …

Background: The number of ulcerative colitis (UC) patients is increasing in Japan and other
countries. Selective depletion of myeloid lineage leucocytes by adsorptive granulocyte and …

Background Adsorptive granulocyte and monocyte apheresis (GMA) with an Adacolumn in
patients with ulcerative colitis (UC) has been applied as a non-pharmacological treatment …

Background. Recently, granulocyte and monocyte adsorption apheresis (GMA) has been
shown to be effective for active ulcerative colitis (UC). Its original weekly treatment schedule …